| Pharmaceutical active ingredients: |
| Mephentermine Sulfate |
| Available forms, composition and doses of Mephentine: |
| Injectable; Injection; Mephentermine Sulfate 15 mg / mlInjectable; Injection; Mephentermine Sulfate 30 mg / mlTablets; Oral; mephentermine 10 mg |
| Mephentine medical category: |
| Human:Vasoconstrictors |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C01CA11 - Mephentermine |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Wyeth |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Mephaxine Compositum | Guaifenesin; Prenoxdiazine Hydrochloride; Terpin Hydrate | Mepha |
| Mephedan | Mephenesin | Unidentified Pharmaceutical Company |
| Mephelor | Mephenesin | Unidentified Pharmaceutical Company |
| Mephenon | Methadone | Unidentified Pharmaceutical Company |
| Mephensin | Mephenesin | Unidentified Pharmaceutical Company |
| Mepherol | Mephenesin | Unidentified Pharmaceutical Company |
| Mephesin | Mephenesin | Unidentified Pharmaceutical Company |
| Mephetedrine | Mephentermine | Unidentified Pharmaceutical Company |
| Mephin | Mephenesin | Unidentified Pharmaceutical Company |
| Mephine | Mephentermine | Unidentified Pharmaceutical Company |